Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Evidence-based guidelines for the management of abnormally invasive placenta: recommendations from the International Society for Abnormally Invasive Placenta

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Harvard

Collins, SL, Alemdar, B, van Beekhuizen, HJ, Bertholdt, C, Braun, T, Calda, P, Delorme, P, Duvekot, JJ, Gronbeck, L, Kayem, G, Langhoff-Roos, J, Marcellin, L, Martinelli, P, Morel, O, Mhallem, M, Morlando, M, Noergaard, LN, Nonnenmacher, A, Pateisky, P, Petit, P, Rijken, MJ, Ropacka-Lesiak, M, Schlembach, D, Sentilhes, L, Stefanovic, V, Strindfors, G, Tutschek, B, Vangen, S, Weichert, A, Weizsäcker, K, Chantraine, F & International Society for Abnormally Invasive Placenta (IS-AIP) 2019, 'Evidence-based guidelines for the management of abnormally invasive placenta: recommendations from the International Society for Abnormally Invasive Placenta' American Journal of Obstetrics and Gynecology, bind 220, nr. 6, s. 511-526. https://doi.org/10.1016/j.ajog.2019.02.054

APA

Collins, S. L., Alemdar, B., van Beekhuizen, H. J., Bertholdt, C., Braun, T., Calda, P., ... International Society for Abnormally Invasive Placenta (IS-AIP) (2019). Evidence-based guidelines for the management of abnormally invasive placenta: recommendations from the International Society for Abnormally Invasive Placenta. American Journal of Obstetrics and Gynecology, 220(6), 511-526. https://doi.org/10.1016/j.ajog.2019.02.054

CBE

Collins SL, Alemdar B, van Beekhuizen HJ, Bertholdt C, Braun T, Calda P, Delorme P, Duvekot JJ, Gronbeck L, Kayem G, Langhoff-Roos J, Marcellin L, Martinelli P, Morel O, Mhallem M, Morlando M, Noergaard LN, Nonnenmacher A, Pateisky P, Petit P, Rijken MJ, Ropacka-Lesiak M, Schlembach D, Sentilhes L, Stefanovic V, Strindfors G, Tutschek B, Vangen S, Weichert A, Weizsäcker K, Chantraine F, International Society for Abnormally Invasive Placenta (IS-AIP). 2019. Evidence-based guidelines for the management of abnormally invasive placenta: recommendations from the International Society for Abnormally Invasive Placenta. American Journal of Obstetrics and Gynecology. 220(6):511-526. https://doi.org/10.1016/j.ajog.2019.02.054

MLA

Vancouver

Author

Collins, Sally L ; Alemdar, Bahrin ; van Beekhuizen, Heleen J ; Bertholdt, Charline ; Braun, Thorsten ; Calda, Pavel ; Delorme, Pierre ; Duvekot, Johannes J ; Gronbeck, Lene ; Kayem, Gilles ; Langhoff-Roos, Jens ; Marcellin, Louis ; Martinelli, Pasquale ; Morel, Olivier ; Mhallem, Mina ; Morlando, Maddalena ; Noergaard, Lone N ; Nonnenmacher, Andreas ; Pateisky, Petra ; Petit, Philippe ; Rijken, Marcus J ; Ropacka-Lesiak, Mariola ; Schlembach, Dietmar ; Sentilhes, Loïc ; Stefanovic, Vedran ; Strindfors, Gita ; Tutschek, Boris ; Vangen, Siri ; Weichert, Alexander ; Weizsäcker, Katharina ; Chantraine, Frederic ; International Society for Abnormally Invasive Placenta (IS-AIP). / Evidence-based guidelines for the management of abnormally invasive placenta : recommendations from the International Society for Abnormally Invasive Placenta. I: American Journal of Obstetrics and Gynecology. 2019 ; Bind 220, Nr. 6. s. 511-526.

Bibtex

@article{a1c3e3d906a04a85af209214d325d8da,
title = "Evidence-based guidelines for the management of abnormally invasive placenta: recommendations from the International Society for Abnormally Invasive Placenta",
abstract = "The worldwide incidence of abnormally invasive placenta is rapidly rising, following the trend of increasing cesarean delivery. It is a heterogeneous condition and has a high maternal morbidity and mortality rate, presenting specific intrapartum challenges. Its rarity makes developing individual expertise difficult for the majority of clinicians. The International Society for Abnormally Invasive Placenta aims to improve clinicians' understanding and skills in managing this difficult condition. By pooling knowledge, experience, and expertise gained within a variety of different healthcare systems, the Society seeks to improve the outcomes for women with abnormally invasive placenta globally. The recommendations presented herewith were reached using a modified Delphi technique and are based on the best available evidence. The evidence base for each is presented using a formal grading system. The topics chosen address the most pertinent questions regarding intrapartum management of abnormally invasive placenta with respect to clinically relevant outcomes, including the following: definition of a center of excellence; requirement for antenatal hospitalization; antenatal optimization of hemoglobin; gestational age for delivery; antenatal corticosteroid administration; use of preoperative cystoscopy, ureteric stents, and prophylactic pelvic arterial balloon catheters; maternal position for surgery; type of skin incision; position of the uterine incision; use of interoperative ultrasound; prophylactic administration of oxytocin; optimal method for intraoperative diagnosis; use of expectant management; adjuvant therapies for expectant management; use of local surgical resection; type of hysterectomy; use of delayed hysterectomy; intraoperative measures to treat life-threatening hemorrhage; and fertility after conservative management.",
keywords = "Adrenal Cortex Hormones/therapeutic use, Cesarean Section, Conservative Treatment, Delphi Technique, Disease Management, Female, Gestational Age, Hospitalization, Humans, Hysterectomy, Oxytocics/therapeutic use, Oxytocin/therapeutic use, Patient Positioning, Placenta Accreta/therapy, Postpartum Hemorrhage/prevention & control, Pregnancy, Stents, Ureter, Watchful Waiting",
author = "Collins, {Sally L} and Bahrin Alemdar and {van Beekhuizen}, {Heleen J} and Charline Bertholdt and Thorsten Braun and Pavel Calda and Pierre Delorme and Duvekot, {Johannes J} and Lene Gronbeck and Gilles Kayem and Jens Langhoff-Roos and Louis Marcellin and Pasquale Martinelli and Olivier Morel and Mina Mhallem and Maddalena Morlando and Noergaard, {Lone N} and Andreas Nonnenmacher and Petra Pateisky and Philippe Petit and Rijken, {Marcus J} and Mariola Ropacka-Lesiak and Dietmar Schlembach and Lo{\"i}c Sentilhes and Vedran Stefanovic and Gita Strindfors and Boris Tutschek and Siri Vangen and Alexander Weichert and Katharina Weizs{\"a}cker and Frederic Chantraine and {International Society for Abnormally Invasive Placenta (IS-AIP)}",
note = "Copyright {\circledC} 2019 Elsevier Inc. All rights reserved.",
year = "2019",
month = "6",
doi = "10.1016/j.ajog.2019.02.054",
language = "English",
volume = "220",
pages = "511--526",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby, Inc",
number = "6",

}

RIS

TY - JOUR

T1 - Evidence-based guidelines for the management of abnormally invasive placenta

T2 - recommendations from the International Society for Abnormally Invasive Placenta

AU - Collins, Sally L

AU - Alemdar, Bahrin

AU - van Beekhuizen, Heleen J

AU - Bertholdt, Charline

AU - Braun, Thorsten

AU - Calda, Pavel

AU - Delorme, Pierre

AU - Duvekot, Johannes J

AU - Gronbeck, Lene

AU - Kayem, Gilles

AU - Langhoff-Roos, Jens

AU - Marcellin, Louis

AU - Martinelli, Pasquale

AU - Morel, Olivier

AU - Mhallem, Mina

AU - Morlando, Maddalena

AU - Noergaard, Lone N

AU - Nonnenmacher, Andreas

AU - Pateisky, Petra

AU - Petit, Philippe

AU - Rijken, Marcus J

AU - Ropacka-Lesiak, Mariola

AU - Schlembach, Dietmar

AU - Sentilhes, Loïc

AU - Stefanovic, Vedran

AU - Strindfors, Gita

AU - Tutschek, Boris

AU - Vangen, Siri

AU - Weichert, Alexander

AU - Weizsäcker, Katharina

AU - Chantraine, Frederic

AU - International Society for Abnormally Invasive Placenta (IS-AIP)

N1 - Copyright © 2019 Elsevier Inc. All rights reserved.

PY - 2019/6

Y1 - 2019/6

N2 - The worldwide incidence of abnormally invasive placenta is rapidly rising, following the trend of increasing cesarean delivery. It is a heterogeneous condition and has a high maternal morbidity and mortality rate, presenting specific intrapartum challenges. Its rarity makes developing individual expertise difficult for the majority of clinicians. The International Society for Abnormally Invasive Placenta aims to improve clinicians' understanding and skills in managing this difficult condition. By pooling knowledge, experience, and expertise gained within a variety of different healthcare systems, the Society seeks to improve the outcomes for women with abnormally invasive placenta globally. The recommendations presented herewith were reached using a modified Delphi technique and are based on the best available evidence. The evidence base for each is presented using a formal grading system. The topics chosen address the most pertinent questions regarding intrapartum management of abnormally invasive placenta with respect to clinically relevant outcomes, including the following: definition of a center of excellence; requirement for antenatal hospitalization; antenatal optimization of hemoglobin; gestational age for delivery; antenatal corticosteroid administration; use of preoperative cystoscopy, ureteric stents, and prophylactic pelvic arterial balloon catheters; maternal position for surgery; type of skin incision; position of the uterine incision; use of interoperative ultrasound; prophylactic administration of oxytocin; optimal method for intraoperative diagnosis; use of expectant management; adjuvant therapies for expectant management; use of local surgical resection; type of hysterectomy; use of delayed hysterectomy; intraoperative measures to treat life-threatening hemorrhage; and fertility after conservative management.

AB - The worldwide incidence of abnormally invasive placenta is rapidly rising, following the trend of increasing cesarean delivery. It is a heterogeneous condition and has a high maternal morbidity and mortality rate, presenting specific intrapartum challenges. Its rarity makes developing individual expertise difficult for the majority of clinicians. The International Society for Abnormally Invasive Placenta aims to improve clinicians' understanding and skills in managing this difficult condition. By pooling knowledge, experience, and expertise gained within a variety of different healthcare systems, the Society seeks to improve the outcomes for women with abnormally invasive placenta globally. The recommendations presented herewith were reached using a modified Delphi technique and are based on the best available evidence. The evidence base for each is presented using a formal grading system. The topics chosen address the most pertinent questions regarding intrapartum management of abnormally invasive placenta with respect to clinically relevant outcomes, including the following: definition of a center of excellence; requirement for antenatal hospitalization; antenatal optimization of hemoglobin; gestational age for delivery; antenatal corticosteroid administration; use of preoperative cystoscopy, ureteric stents, and prophylactic pelvic arterial balloon catheters; maternal position for surgery; type of skin incision; position of the uterine incision; use of interoperative ultrasound; prophylactic administration of oxytocin; optimal method for intraoperative diagnosis; use of expectant management; adjuvant therapies for expectant management; use of local surgical resection; type of hysterectomy; use of delayed hysterectomy; intraoperative measures to treat life-threatening hemorrhage; and fertility after conservative management.

KW - Adrenal Cortex Hormones/therapeutic use

KW - Cesarean Section

KW - Conservative Treatment

KW - Delphi Technique

KW - Disease Management

KW - Female

KW - Gestational Age

KW - Hospitalization

KW - Humans

KW - Hysterectomy

KW - Oxytocics/therapeutic use

KW - Oxytocin/therapeutic use

KW - Patient Positioning

KW - Placenta Accreta/therapy

KW - Postpartum Hemorrhage/prevention & control

KW - Pregnancy

KW - Stents

KW - Ureter

KW - Watchful Waiting

U2 - 10.1016/j.ajog.2019.02.054

DO - 10.1016/j.ajog.2019.02.054

M3 - Journal article

VL - 220

SP - 511

EP - 526

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 6

ER -

ID: 59154491